Alcoholic Liver Disease Strategies for Seamless Care or An Clinical Approach to the Jaundiced Alcoholic Patient
|
|
- Lesley Armstrong
- 5 years ago
- Views:
Transcription
1 Alcoholic Liver Disease Strategies for Seamless Care or An Clinical Approach to the Jaundiced Alcoholic Patient Liver Disease for the General Physician Royal College of Physicians July 2017 Dr Ewan Forrest Glasgow Royal Infirmary
2 Increasing Burden of Alcoholic Liver Disease >60% increase in discharges with alcoholic liver disease 2000/1 to 2009/ % increase in alcohol-related deaths 1980 to 2010.
3 The start of another medical receiving ward round year old woman history of alcohol excess; flu-like symptoms for 5 days increasingly unwell; yellow eyes Bilirubin 126; AST 3241; ALT 1194; ALP 234; PTr 3.9 Jaundiced; no ascites evident What is this likely to be? A. Alcoholic Hepatitis B. Acute Liver Injury C. Portal Vein Thrombosis D. Decompensated Alcoholic Cirrhosis E. Ascending Cholangitis
4 Biochemical Patterns of Alcoholic Liver Disease De Ritis Ratio Decision Limit Condition < to < to < Healthy Women (up to 1.7) Men (up to 1.3) Children Neonate Acute Viral Hepatitis Resolving Worsening Fulminant Alcoholic Liver Disease Resolving Alcohol Abuse Acute Hepatitis Chronic Liver Disease Stable Fibrosis risk Other Causes Muscle Disease Chronic Resolving Acute Raised AST : ALT ratio (De Ritis Ratio) AST not >500 (ALT usually <300)
5 The Jaundiced Alcoholic: Scenario 1 Acute Liver Injury In context of either no background fibrotic liver disease or established cirrhosis Atypical biochemistry; clinical context Possible Causes Drug induced: even therapeutic paracetamol Acute viral infection (HAV; HBV; HEV) Ischaemic/ Hypoxic hepatitis Co-incident primary liver disease: AIH
6 Another ward round in an alternate universe year old woman >80g alcohol per day; abdominal and ankle swelling increasingly unwell for 6 months; yellow eyes for 4 months Bilirubin 105; AST 93; ALT 32; ALP 234; PT 22 seconds (PTr 1.9); Urea 6.5; WCC 3.4 Jaundiced; drowsy; moderate abdominal distension; hepatic flap present. What is this likely to be? A. Alcoholic Hepatitis B. Acute Liver Failure C. Acute Portal Vein Thrombosis D. Decompensated Alcoholic Cirrhosis E. Ascending Cholangitis
7 The Jaundiced Alcoholic: Scenario 2 Chronic Decompensation of Chronic Disease In context of established cirrhosis Typical biochemistry; SIRS not florid Clinical Context Progressive deterioration over weeks/ months Jaundice evident >2 months Ascites and encephalopathy often predominant Represents progressive disease with continued drinking but may herald development of hepatoma
8 In the next bed, just arrived year old woman >80g alcohol per day; flu-like symptoms for 5 days increasingly unwell; yellow eyes for 2 weeks Bilirubin 326; AST 241; ALT 94; ALP 234; PT 27seconds (PTr 2.4); Urea 6.5; WCC 17.4 Jaundiced; pyrexial; drowsy; abdominal distension Abdominal US showed large ascites and hepato-splenomegaly. What should we do next? A. Percutaneous liver biopsy B. MRCP C. Transjugular liver biopsy D. CT Head E. Diagnostic Ascitic Aspiration
9 Sepsis in Alcoholic Liver Disease Ascitic Fluid Analysis SBP diagnosed in 20% cirrhotics admitted to hospital, and 2-3% attending for outpatient paracentesis >250 neutrophils/cm 3 (>500 WBC/ cm 3 ) and suggest spontaneous bacterial peritonitis (SBP) Samples to be sent in blood culture bottles Early antibiotics (see local guidelines) and Albumin (20% HAS: 1.5g/kg Day 1; 1g/kg Day 3 for high risk patients: Bilirubin >68 and/or Urea>11)
10 The Jaundiced Alcoholic: Scenario 3 Acute Decompensation of Chronic Disease Precipitant: often GI bleeding/ Sepsis/ Portal Vein Thrombosis Typical biochemistry; SIRS usually evident Clinical Context Can be difficult to differentiate from Alcoholic Hepatitis (and may co-exist) Full sepsis screen: blood cultures; urinalysis and culture; diagnostic ascitic tap; CXR Low threshold for antibiotics (but be wary of gentamicin)
11 BSG/BASL Clinical Bundle for Decompensated Liver Disease: the First 24 hours Stuart McPherson et al. Frontline Gastroenterology
12 Curiously an hour later there arrives year old woman Bilirubin 326; AST 241; ALT 94; ALP 234; PT 27seconds (PTr 2.4); Urea 6.5; WCC 17.4 Jaundiced; pyrexial; drowsy; moderate abdominal distension Abdominal US showed moderate ascites and hepatosplenomegaly. Sepsis screen negative What is this likely to be? A. Alcoholic Hepatitis B. Acute Liver Failure C. Portal Vein Thrombosis D. Decompensated Alcoholic Cirrhosis E. Ascending Cholangitis
13 The Jaundiced Alcoholic: Scenario 4 Clinically relevant Alcoholic Hepatitis Essential Features excess alcohol within 8 weeks < 2 month onset of Bilirubin > 80 mol/l Exclusion/ treatment of sepsis AST < 500 (AST: ALT ratio >1.5) Characteristic Features hepatomegaly fever leucocytosis hepatic bruit NIAAA 2016: Probable Alcoholic Hepatitis Inclusion Criteria Onset of jaundice within prior 8 weeks Ongoing consumption of > 40 (female) or 60 (males) g alcohol/day for 6 months with <60 days of abstinence before the onset of jaundice Aspartate aminotransferase > 50, aspartate aminotransferase/alanine aminotransferase > 1.5, and both values < 400 IU/L Serum bilirubin (total) > 3.0 mg/dl (50µmol/l) Liver biopsy confirmation in patients with confounding factors
14 Back to our patient year old woman Bilirubin 326; AST 241; ALT 94; ALP 234; PT 27seconds (PTr 2.4); Urea 6.5; WCC 17.4 Jaundiced; pyrexial; drowsy; moderate abdominal distension Abdominal US showed moderate ascites and hepatosplenomegaly. What is her short-term (28 day)prognosis? A. Excellent (>95% survival) B. Reasonable (~80% survival) C. Moderate (~60% survival) D. Poor (~50% survival) E. Terrible (<40% survival)
15 We Need to Talk About Maddrey... DF: the usual means of identifying severe alcoholic hepatitis DF = 4.6 (PT PATIENT PT CONTROL ) + Serum Bilirubin ( mol/l) / 17 BUT Concerns regarding accuracy (50%) Kulkarni et al, patients C-statistic: Wide variation in the measurement of prothrombin time
16 Sensitivity The Glasgow Alcoholic Hepatitis Score Specificity DF GAHS DF GAHS AUC: GAHS = ( ) DF = ( ) (p=0.014) Day 1 Data Day 28 Outcome (Accuracy) Score Given Age < WCC (10 9 /l) < Urea (mmol/l) < PT ratio/ INR < > 2.0 Bilirubin ( mol/l) < > 250 Day 84 Outcome (Accuracy) GAHS</ 9 81% 75% DF</ 32 49% 53% AUC: GAHS = ( ) DF = ( ) (p=0.014) Day 6-9 Data GAHS</ 9 81% 78% DF</ 32 52% 57%
17 Alternatives to GAHS: MELD=3.8 x log e (bilirubin, mg/dl) x log e (INR)+ 9.6 x log e (creatinine,mg/dl) ABIC=(age*0.1)+(bilirubin*0.08)+(creatinine*0.3)+(INR*0.8) < % survival % survival >9.0 22% survival Lille Score: R = (0.101*age in years) + (0.147*albumin day 0 in g/l) + (0.0165*evolution in bilirubin level in M) - (0.206*renal insufficiency) # - (0.0065*bilirubin day 0 in M) - (0.0096*INR) # creatinine>115 M Score = EXP(-R) / [1+EXP(-R)]
18 Back to our patient year old woman Bilirubin 326; AST 241; ALT 94; ALP 234; PT 27seconds (PTr 2.4); Urea 6.5; WCC 17.4; Alb 26 Jaundiced; pyrexial; drowsy; moderate abdominal distension US showed moderate ascites and hepato-splenomegaly. Sepsis screen negative What treatment should be considered? A. Terlipressin and Albumin infusions B. Pentoxifylline orally C. Prednisolone orally D. Rifaximin E. Broad spectrum antibiotics
19 STeroids Or Pentoxifylline for Alcoholic Hepatitis Pentoxifylline 400mg tds; Prednisolone 40mg: each for 4 weeks Primary End-point: 28 Day mortality Pentoxifylline No Yes Total No 16.7% (45/269) 19.4% (50/258) 18.0% (95/527) Prednisolone Yes 14.3% (38/266) 13.5% (35/260) 13.9% (73/526) Total 15.5% (83/535) 16.4% (85/518) 16.0% (168/1053)
20 Prednisolone vs No Prednislone STOPAH: Mortality Pentoxifylline vs No Pentoxifylline OR = 0.72 ( ) p = OR = 1.02 ( ) p = OR = 1.07 ( ) p = OR = 0.97 ( ) p = OR = 1.01 ( ) p = OR = 0.99 ( ) p = 0.972
21 Determinants of 28 Day Outcome Multivariate and Meta- Analysis Multivariate Analysis Variable Odds ratio (95% CI) p-value Prednisolone vs no prednisolone ( ) Prothrombin ratio ( ) Bilirubin ( ) Age ( ) <0.001 White Blood Cells ( ) Urea ( ) Creatinine ( ) Hepatic Encephalopathy ( ) <0.001
22 Risks of Prednisolone in Alcoholic Hepatitis: Infection Placebo/ Placebo (n=272) Pred/ Placebo (n=274) Placebo/ PTX (n=273) Pred/ PTX (n=273) Infection developed in 13% of those who received prednisolone (cf 7%; p=0.002) Total (n=1092) Infections and infestations 27 (20%) 44 (24%) 16 (11%) 30 (19%) 117 (19%) Lung infection 11 (8%) 20 (11%) 6 (4%) 18 (11%) 55 (9%) Vergis et al, 2017: for patients who present with infection If not receiving prednisolone, continuation of antibiotics does not impact upon mortality If receiving prednisolone concurrent antibiotic therapy significantly reduces mortality
23 Corticosteroid Responsiveness: baseline disease severity *p<0.05 cf no treatment #p<0.005 cf no treatment
24 Corticosteroid Responsiveness : Day 7 Progress Mathurin et al, patients: DF 32, biopsy-proven AH. ECBL response. Louvet et al, patients: DF 32, biopsy-proven; 118 in validation set. Lille model
25 Intensive Enteral Nutrition in Alcoholic Moreno et al 2016 Hepatitis Conventional nutrition or intensive EN: 14 days NG tube 48.5% premature NG tube removal: 3 cases of aspiration No increased risk of upper GI bleeding 6 month mortality: 44.4% with EN; 52.1% without (p=0.406) Improved survival if 1692kcal/day or 21.5kcal/kg/day irrespective of treatment group
26 GAHS EASL Guidelines 2012?
27 Just then in the next bed... Patient with known alcohol related cirrhosis Admitted 36 hours earlier with jaundice Increasing confusion with agitation Now shouting and threatening staff and other patients How should her agitation be managed? A. Regular Diazepam B. Symptom-triggered Diazepam C. Symptom-triggered Lorazepam D. Intravenous Chlormethiazole E. 5-10mg Haloperidol
28 Confusion and Agitation in the Jaundiced Alcoholic: a Broad Differential Withdrawal State Alcohol; benzodiazepine; (SSRI) Wernicke s Encephalopathy Undernourished; dextrose load; low Mg Hepatic Encephalopathy Acute; Chronic (porto-systemic) Brain Injury Traumatic: subdural (history of falls); chronic ARBD Seizure Disorder Post-ictal: unwitnessed seizure; Non-convulsive Status Delerium/ Metabolic Hyponatraemia; Possible sepsis Intoxication Prolonged effect (unknown street drugs); illicit use (Psychiatric)
29 Alcohol Withdrawal in the Liver Patient NICE Clinical Guidelines 100, 2010: In older adults and people with compromised liver function, long-acting agents are known to accumulate. In the absence of clinical evidence supporting one agent over another, the GDG agreed on consensus that a shorter-acting agent (e.g. oxazepam or lorazepam) could be offered to the elderly or if there was evidence of encephalopathy. Consider Symptom Triggered Treatment (STT) rather than Fixed Dose Treatment (FDT): Lorazepam 1-2mg Haloperidol for severe agitation (note QT interval) Anaesthetic involvement in extreme cases
30 Glasgow Modified Alcohol Withdrawal Score (GMAWS) Tremor 0) No tremor 1) On movement 2) At rest Sweating 0) No sweat visible 1) Moist 2) Drenching sweats Hallucination 0) Not present 1) Dissuadable 2) Not dissuadable Orientation 0) Orientated 1) Vague, detached 2) Disorientated, no contact Agitation 0) Calm 1) Anxious 2) Panicky BSG 2016 Score: (Do not use scoring tool if patient intoxicated; must be at least 8 hours since last drink.) 0: Repeat Score in 2 hours (Discontinue after scoring on 4 consecutive occasions, except if less than 48hrs after last drink) 1 3: Give 10mg Diazepam: Repeat Score in 2 hours 4 8: Give 20mg Diazepam: Repeat Score in 1 hour 9-10: Give 20mg Diazepam : Repeat Score in 1 hour; discuss with medical staff Derived from Foy et al, 2006 and Swift et al, Preferred by nursing staff in acute medical units compared with CIWA-Ar (McPherson et al, 2012).
31 Importance of abstinence... Alcohol Consumption at Day 90 n Odds ratio 1 year mortality 95% CI p- value Not reduced (still drinking as much or more than when presented) vs Abstinent <0.001 Reduced drinking but above safety limits vs Abstinent Reduced drinking to below safety limits vs Abstinent
32 Pharmacotherapy Options in ALD Little evidence with significant alcohol-related liver injury. Acamprosate has the best safety profile. No hepatic metabolism and no reported hepatotoxicity. Acamprosate does not adversely affect neuropsychiatric status in patients with Child's Grade A and B cirrhosis. Naltrexone not associated with hepatotoxicity Disulfiram related to hepatotoxicity: 28% mortality Baclofen: Addolorata et al, 2007 alcoholic cirrhosis; Baclofen 10mg tds for 12 weeks 71% abstinent (cf 29%): OR 6.3 (2.4, 16.1), p= excluded people with diabetes, encephalopathy, psychiatric comorbidity and comorbid drug misuse
33 The Jaundiced Alcoholic: an approach Is it Alcohol? Look for other precipitants; atypical biochemical pattern Is it chronic decompensation or a more acute change? >2 month history; relative lack of SIRS; typical biochemistry If acute, is there sepsis or other trigger? Full sepsis screen; Abdo US; early treatment If acute and no sepsis, likely alcoholic hepatitis Assess severity: Prednisolone 40mg for 4 weeks if GAHS>8 and improvement after 7 days; continue antibiotics if sepsis For ALL patients: Address general nutrition and specific deficits (Folate; B1; Mg) Manage AWS safely Engage with alcohol services
Alcoholic Hepatitis: Routine Screening for Early Recognition and Management. Juan Guerrero, MD
Alcoholic Hepatitis: Routine Screening for Early Recognition and Management Juan Guerrero, MD Global Problem 1% of GNP of medium/high income countries Additional societal costs Disproportionately affects
More informationTherapeutic Strategy in Severe Alcoholic Hepatitis: Present to future development of New
Therapeutic Strategy in Severe Alcoholic Hepatitis: Present to future development of New Philippe Mathurin Service Maladies de l Appareil Digestif Inserm U995 Hôpital Claude Huriez Lille France molecules
More informationAlcoholic Hepatitis: Management Options
Alcoholic Hepatitis: Management Options Paul J. Thuluvath, MD. FRCP Institute of Digestive Health & Liver Diseases, Mercy Medical Center, Baltimore Professor of Surgery & Medicine, Georgetown University,
More informationManagement of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL
Management of Acute Decompensation of Cirrhosis JOHN O GRADY KING S COLLEGE HOSPITAL Terminology Acute decompensation of cirrhosis - stable patient with sudden deterioration Acute-on-chronic liver failure
More informationManagement of Alcoholic Liver Disease. Hafez Fakheri Professor of medicine, Sari, Iran
Management of Alcoholic Liver Disease Hafez Fakheri Professor of medicine, Sari, Iran Alcoholic Hepatitis Scores DF = (4.6 x [ PT- control PT]) + (bili ) MELD = 10 * ((0.957 * ln(cr)) + (0.378 * ln(bil))
More informationPaul Martin, MD, FACG. University of Miami. 30,000 deaths from cirrhosis per annum, alcohol implicated in 48%
Paul Martin, MD, FACG University of Miami 30,000 deaths from cirrhosis per annum, alcohol implicated in 48% Second commonest indication for liver transplant NIAA 2007 Page 1 of 26 Risk Factors Medical
More informationKey Aspects of Diagnosing Alcoholic Hepatitis. Mark Sonderup University of Cape Town & Groote Schuur Hospital
Key Aspects of Diagnosing Alcoholic Hepatitis Mark Sonderup University of Cape Town & Groote Schuur Hospital 42 year old woman, married with 3 children No significant co-morbidities or illnesses Habits
More informationCONTROLLED DOCUMENT. Cirrhosis Care Bundle CATEGORY: Clinical Guidelines. CLASSIFICATION: Clinical. Controlled Document CG201 Number:
Cirrhosis Care Bundle CONTROLLED DOCUMENT CATEGORY: Clinical Guidelines CLASSIFICATION: Clinical Controlled Document CG201 Number: Version Number: 1 Controlled Document Clinical Guidelines Group Sponsor:
More informationComplications of Cirrhosis
Complications of Cirrhosis Causes of Cirrhosis Alcohol Chronic Viral Hepatitis (B/C) Haemochromatosis Autoimmune Hepatitis NAFLD/NASH Primary Biliary Cirrhosis Primary Sclerosing Cholangitis 1-AT deficiency
More informationThe Yellow Patient. Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust
The Yellow Patient Dr Chiradeep Raychaudhuri, Consultant Hepatologist, Hull University Teaching Hospitals NHS Trust there s a yellow patient in bed 40. It s one of yours. Liver Cirrhosis Why.When.What.etc.
More informationAlcohol withdrawal. Clinical features
Alcohol withdrawal Clinical features Severity increase with amount consumed; uncommon with < drinks per day. Predictable pattern: patients with previous withdrawal seizures are at high risk for recurrence.
More informationACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries
ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Ashwani K. Singal, MD, MS, FACG 1, Ramon Bataller, MD, PhD, FACG 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick S. Kamath,
More informationA lcoholic hepatitis is perhaps the most florid manifestation
1174 ALCOHOLIC LIVER DISEASE Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score E H Forrest, C D J Evans, S Stewart,
More informationALCOHOLIC LIVER DISEASE (ALD) Nayan Patel, DO Transplant Hepatology/GI Banner Advanced Liver Disease and Transplant Center
ALCOHOLIC LIVER DISEASE (ALD) Nayan Patel, DO Transplant Hepatology/GI Banner Advanced Liver Disease and Transplant Center Objectives Spectrum of alcoholic liver disease Focus on Alcoholic Hepatitis (AH)
More informationManagement of Alcoholic Hepatitis
Management of Alcoholic Hepatitis Richard K. Sterling, MD, MSc, FACP, FACG, FAASLD, AGAF VCU Hepatology Professor of Medicine Chief, Section of Hepatology Program Director, Transplant Hepatology Virginia
More informationCHAPTER 1. Alcoholic Liver Disease
CHAPTER 1 Alcoholic Liver Disease Major Lesions of Alcoholic Liver Disease Alcoholic fatty liver - >90% of binge and chronic drinkers Alcoholic hepatitis precursor of cirrhosis Alcoholic cirrhosis end
More informationAmmonia level at admission predicts in-hospital mortality for patients with alcoholic hepatitis
Gastroenterology Report, 5(3), 2017, 232 236 doi: 10.1093/gastro/gow010 Advance Access Publication Date: 1 May 2016 Original article ORIGINAL ARTICLE Ammonia level at admission predicts in-hospital mortality
More informationWEEK. MPharm Programme. Liver Biochemistry. Slide 1 of 49 MPHM14 Liver Biochemistry
MPharm Programme Liver Biochemistry Slide 1 of 49 MPHM Liver Biochemistry Learning Outcomes Assess and evaluate the signs and symptoms of illness Assess and critically appraise a patients medication regimen,
More informationHEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management
HEPATOrenal Syndrome Type I: Correct Diagnosis = Correct Management Stephen G. M. Wong BSc, BSc(Med), MD, MHSc, FRCPC Associate Professor of Medicine Director, Hepatology Education Section of Hepatology
More informationOVERVIEW OF ALD ALCOHOLIC LIVER DISEASE DISCLOSURE
ALCOHOLIC LIVER DISEASE KEVIN D MULLEN MD West Virginia University Morgantown WV DISCLOSURE I have nothing to disclose. AMOUNT OF ALCOHOL PER STANDARD DRINK > (30 ) GRAM OF ALCOHOL PER DAY USA Canada UK
More informationManagement of Cirrhosis Related Complications
Management of Cirrhosis Related Complications Ke-Qin Hu, MD, FAASLD Professor of Clinical Medicine Director of Hepatology University of California, Irvine Disclosure I have no disclosure related to this
More informationGuidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust
Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Authors: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Dr Tasneem Pirani, ST4 in
More informationCirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association
CIRRHOSIS AND PORTAL HYPERTENSION Cirrhosis and Portal Hypertension Gastroenterology Teaching Project American Gastroenterological Association WHAT IS CIRRHOSIS? What is Cirrhosis? DEFINITION OF CIRRHOSIS
More informationLiver failure &portal hypertension
Liver failure &portal hypertension Objectives: by the end of this lecture each student should be able to : Diagnose liver failure (acute or chronic) List the causes of acute liver failure Diagnose and
More informationDrug Induced Liver Injury (DILI)
Drug Induced Liver Injury (DILI) Aisling Considine- Consultant Hepatology Pharmacist. King s College Hospital NHS Foundation Trust aislingconsidine@nhs.net Drug Induced Liver Injury /Disease Acute Liver
More information4/3/2014. Elizabeth Thompson, PharmD April Understand the importance of the liver and basic physiology.
Liver Disease Elizabeth Thompson, PharmD thompse@sarmc.org April 2014 Objectives Understand the importance of the liver and basic physiology. Review hepatic disorders Recognize liver function scoring systems
More informationManagement of acute alcoholic hepatitis
Management of acute alcoholic hepatitis Yesim ALAHDAB Marmara University Hospital, Istanbul/TURKEY 5 th European Young Hepatologists Workshop August, 27-29, 2015 Moulin de Vernègues, France 1.4L ALCOHOL
More informationGI bleeding in chronic liver disease
GI bleeding in chronic liver disease Stuart McPherson Consultant Hepatologist Liver Unit, Freeman Hospital, Newcastle upon Tyne and Institute of Cellular Medicine, Newcastle University. Case 54 year old
More informationAlcoholic Hepatitis. Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck. Herbert Tilg
Alcoholic Hepatitis Christian Doppler Research Laboratory for Gut Inflammation Medical University Innsbruck Herbert Tilg Overview Background I: Alcoholic steatohepatitis (ASH) is a severe and often life-threatening
More informationManagement of autoimmune hepatitis. Pierre-Emmanuel RAUTOU Inserm U970, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France
Management of autoimmune hepatitis Pierre-Emmanuel RAUTOU Inserm U970, PARCC@HEGP, Paris Service d hépatologie, Hôpital Beaujon, Clichy, France 41 year-old woman, coming to emergency department for fatigue
More informationAlcohol-Related Liver Disease
Alcohol-Related Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD) 1 Why is the liver important? Your liver is a vital organ that performs many essential functions. It filters out harmful substances
More informationCase Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis
Diagnostic Problems in Hepatology 181 Case Report: Acute-on-Chronic Liver Failure: Making the Diagnosis between Infection and Acute Alcoholic Hepatitis Carmen Sendra, MD 1 Javier Ampuero, MD, PhD 1,2 Álvaro
More informationIndian Journal of Basic and Applied Medical Research; June 2017: Vol.-6, Issue- 3, P
Original article: Study of usefulness of Discriminant Function (DF) and Glasgow Alcoholic Hepatitis Score (GAHS) in treatment of patients of Alcoholic Hepatitis in Indian Population Dr Mugdha Thakur, Dr
More informationACG Clinical Guideline: Alcoholic Liver Disease
CLINICAL GUIDELINES 1 ACG Clinical Guideline: Alcoholic Liver Disease Ashwani K. Singal, MD, MS, FACG 1, R amon B at a l l e r, M D, Ph D, FAC G 2, Joseph Ahn, MD, MS, FACG (GRADE Methodologist) 3, Patrick
More informationOverview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN
Overview of PSC Jayant A. Talwalkar, MD, MPH Associate Professor of Medicine Mayo Clinic Rochester, MN 2012 Annual Conference PSC Partners Seeking a Cure May 5, 2012 Primary Sclerosing Cholangitis Multifocal
More informationKing s College Hospital NHS Foundation Trust. Acute Liver Disease: what you really need to know.
King s College Hospital NHS Foundation Trust Acute Liver Disease: what you really need to know. William Bernal Professor of Liver Critical Care Liver Intensive Therapy Unit Institute of Liver Studies Kings
More informationInfections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital
Infections In Cirrhotic patients Dr Abid Suddle Institute of Liver Studies King s College Hospital Infection in cirrhotic patients Leading cause morbidity/mortality Common: 30-40% of hospitalised cirrhotic
More informationVIRAL HEPATITIS. Definitions. Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Acute Viral Hepatitis Symptoms
Acute Liver Disease (Hepatitis A &E, Alcoholic hepatitis, DILI and ALF) Definitions AST and ALT Markers of hepatocellular injury Ryan M. Ford, MD Assistant Professor of Medicine Director of Viral Hepatitis
More informationWhite cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
Hardy et al. BMC Gastroenterology 2013, 13:55 RESEARCH ARTICLE Open Access White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers Timothy Hardy
More informationUNIVERSITY OF CALGARY. Jack X.Q. Pang A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE
UNIVERSITY OF CALGARY Epidemiology and Outcomes of Alcoholic Hepatitis in Calgary: A Population-based Study by Jack X.Q. Pang A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT
More informationLIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017
LIVER DISORDERS (PRACTICAL MANAGEMENT) Dr Pok Kern (PK) TAN Gastroenterologist Calvary hospital, ACT 1 st April 2017 TOPICS TO COVER Acute liver failure Chronic liver failure Portal hypertension : Ascites
More informationNCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease
NCEPOD - Measuring the Units; A review of patients who died with alcohol-related liver disease Hospital Number Admission to hospital 5. Trusts should ensure that medical patients are reviewed by a consultant
More informationMANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT
MANAGEMENT OF LIVER CIRRHOSIS: PRACTICE ESSENTIALS AND PATIENT SELF-MANAGEMENT Sherona Bau, ACNP The Pfleger Liver Institute 200 UCLA Medical Plaza, Suite 214 Los Angeles, CA 90095 September 30, 2017 I
More informationHepatology on the AMU
Hepatology on the AMU RCP day, 8 th February 2018 Jo Leithead Consultant in Hepatology and Liver Transplantation Addenbrookes Hospital Cambridge Is liver disease relevant to me? Williams R, Lancet 2014
More informationALCOHOL WITHDRAWAL GUIDELINES
ALCOHOL WITHDRAWAL GUIDELINES Policy author Accountable Executive Lead Approving body Policy reference Dr M Lewis, Gastroenterologist; Professor J A Vale, Clinical Toxicologist; Dr D A Robertson, Alcohol
More informationClinical Case Maria Butí, MD, PhD
Clinical Case Maria Butí, MD, PhD Liver Unit, Internal Medicine Department Vall d Hebron Hospital 1 Clinical Case 70 year-old male Smoker, no alcohol intake No risk factors Diabetes Mellitus treated with
More informationManagement of Cirrhotic Complications Uncontrolled Ascites. Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University
Management of Cirrhotic Complications Uncontrolled Ascites Siwaporn Chainuvati, MD Siriraj Hospital Mahidol University Topic Definition, pathogenesis Current therapeutic options Experimental treatments
More informationLIVER CIRRHOSIS. The liver extracts nutrients from the blood and processes them for later use.
LIVER CIRRHOSIS William Sanchez, M.D. & Jayant A. Talwalkar, M.D., M.P.H. Advanced Liver Disease Study Group Miles and Shirley Fiterman Center for Digestive Diseases Mayo College of Medicine Rochester,
More informationConflicts of Interest in the last 12 months
STEATOHEPATITIS Richard K. Sterling, MD, MSc, FACP, FACG VCU Hepatology Professor of Medicine Chief, Section of Hepatology Virginia Commonwealth University Richmond, VA Conflicts of Interest in the last
More informationDRAFT FOR CONSULTATION
1) What is the accuracy of a tool and/or clinical judgement for the a) assessment b) monitoring of patients at risk of acute alcohol withdrawal? 2) Does the assessment and monitoring of patients with acute
More informationModule 1 Introduction of hepatitis
Module 1 Introduction of hepatitis 1 Training Objectives At the end of the module, trainees will be able to ; Demonstrate improved knowledge of the global epidemiology of the viral hepatitis Understand
More informationHepatology for the Nonhepatologist
Hepatology for the Nonhepatologist Kenneth E. Sherman, MD, PhD Gould Professor of Medicine Director, Division of Digestive Diseases University of Cincinnati College of Medicine Cincinnati, Ohio Learning
More informationUniversity Hospitals of Leicester NHS Trust
University Hospitals of Leicester NHS Trust ACUTE ALCOHOL WITHDRAWAL MANAGEMENT Guidelines for Management of Acute Medical Emergencies Approved By: Policy and Guideline Committee Date Approved: 21 November
More informationA Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis
306 ORIGINAL CONTRIBUTIONS see related editorial on page x A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis Mauricio Garcia-Saenz-de-Sicilia, MD 1, 9,
More informationLiver Transplantation Evaluation: Objectives
Liver Transplantation Evaluation: Essential Work-Up Curtis K. Argo, MD, MS VGS/ACG Regional Postgraduate Course Williamsburg, VA September 13, 2015 Objectives Discuss determining readiness for transplantation
More informationPrednisolone or Pentoxifylline for Alcoholic Hepatitis
The new england journal of medicine Original Article Prednisolone or Pentoxifylline for Alcoholic Hepatitis Mark R. Thursz, M.D., Paul Richardson, M.D., Michael Allison, Ph.D., Andrew Austin, M.D., Megan
More informationABNORMAL LIVER FUNCTION TESTS. Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust
ABNORMAL LIVER FUNCTION TESTS Dr Uthayanan Chelvaratnam Hepatology Consultant North Bristol NHS Trust INTRODUCTION Liver function tests Cases Non invasive fibrosis measurement Questions UK MORTALITY RATE
More informationAutoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP
Autoimmune Hepatobiliary Diseases PROF. DR. SABEHA ALBAYATI CABM,FRCP Autoimmune hepatobiliary diseases The liver is an important target for immunemediated injury. Three disease phenotypes are recognized:
More informationAcute Liver Failure. Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018
Acute Liver Failure Neil Shah, MD UNC School of Medicine High-Impact Hepatology Saturday, Dec 8 th, 2018 Disclosures None Outline Overview of ALF Management of ALF Diagnosis of ALF Treatments and Support
More informationSteps in Assessing Fibrosis 4/30/2015. Overview of Liver Disease Associated With HCV
Overview of Liver Disease Associated With HCV Marion G. Peters, MD John V. Carbone, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco San Francisco,
More informationDISEASE LEVEL MEDICAL EVIDENCE PROTOCOL
DISEASE LEVEL MEDICAL EVIDENCE PROTOCOL 1. This Protocol sets out the medical evidence that must be delivered to the Administrator for proof of Disease Level. It is subject to such further and other Protocols
More informationOntario s Adult Referral and Listing Criteria for Liver Transplantation
Ontario s Adult Referral and Listing Criteria for Liver Transplantation Version 3.0 Trillium Gift of Life Network Ontario s Adult Referral & Listing Criteria for Liver Transplantation PATIENT REFERRAL
More informationCIRROSI E IPERTENSIONE PORTALE NELLA DONNA
Cagliari, 16 settembre 2017 CIRROSI E IPERTENSIONE PORTALE NELLA DONNA Vincenza Calvaruso, MD, PhD Ricercatore di Gastroenterologia Gastroenterologia & Epatologia, Di.Bi.M.I.S. Università degli Studi di
More informationDiseases of liver. Dr. Mohamed. A. Mahdi 4/2/2019. Mob:
Diseases of liver Dr. Mohamed. A. Mahdi Mob: 0123002800 4/2/2019 Cirrhosis Cirrhosis is a complication of many liver disease. Permanent scarring of the liver. A late-stage liver disease. The inflammation
More informationPrise en charge de l hépatite alcoolique aiguë
Prise en charge de l hépatite alcoolique aiguë Prof Christophe Moreno M.D. Ph.D. Clinical Director, Liver Unit Dept. of Gastroenterology, Hepato-Pancreatology and Digestive Oncology CUB Hôpital Erasme
More informationAlcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective
Alcoholism and Alcohol Liver Disease from a Transplant Hepatology Perspective Clark Kulig, MD Director, Porter Center for Liver Care Denver, CO February 2015 Does quantity of alcohol correlate with liver
More informationNAFLD, NASH, and alcoholic liver disease
NAFLD, NASH, and alcoholic liver disease Jonathan Congeni MD NAFLD, NASH, and alcoholic liver disease Disease overview Epidemiology Pathogenesis Clinical features Labs and imaging Evaluation options Focus
More informationHepatology cases for the generalist. Will Gelson Consultant Hepatologist Addenbrooke s Hospital
Hepatology cases for the generalist Will Gelson Consultant Hepatologist Addenbrooke s Hospital 30 y o man with upper GI haemorrhage Background heavy alcohol use Hxof 3 pint haematemesis P 100, BP 90/40,
More informationEDUCATION PRACTICE. Management of Refractory Ascites. Clinical Scenario. The Problem
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:1187 1191 EDUCATION PRACTICE Management of Refractory Ascites ANDRÉS CÁRDENAS and PERE GINÈS Liver Unit, Institute of Digestive Diseases, Hospital Clínic,
More information4/12/2017. Alcoholism and Liver Disease. Burden of Alcoholic Liver Disease. Overview
Alcoholism and Liver Disease Christopher Chang, MD, PhD Division of Gastroenterology/Hepatology University of New Mexico School of Medicine And New Mexico VA Health Care System April 21, 2017 National
More informationWhat is meant by Thrombotic Microangiopathy (TMA)?
What is meant by Thrombotic Microangiopathy (TMA)? Thrombotic Microangiopathy (TMA) is a group of disorders characterized by injured endothelial cells, microangiopathic hemolytic anemia (MAHA), with its
More informationExample Clinician Educational Material for Providers of Immune Effector Cellular Therapy
Example Clinician Educational Material for Providers of Immune Effector Cellular Therapy Disclaimer: This example is just one of many potential examples of clinician education material that can be provided
More informationChronic Hepatic Disease
Chronic Hepatic Disease 10 th Leading Cause of Death Liver Functions Energy Metabolism Protein Synthesis Solubilization, Transport, and Storage Protects and Clears drugs, damaged cells Causes of Liver
More informationOptimal management of ascites
Optimal management of ascites P. Angeli, Dept. of Medicine, Unit of Internal Medicine and epatology (), University of Padova (Italy) pangeli@unipd.it 10th Paris epatology Conference National Conference
More informationA 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary
A 73 year old man, presents with anaemia. Describe the CT scan. Should see primary gastric cancer,ascites and liver secondary A 73 year old man PS presents with anaemia. Endoscopy and CT scan thorax/abdomen
More informationWorld Health Organization. Western Pacific Region
Standard modules for HBV 1 HBV Module 1 Hepatitis B serological markers and virology 2 Acute hepatitis HAV HBV HCV HDV HEV Case fatality Case fatality Uncommon increases with increases with age age Superinfection
More informationDecompensated chronic liver disease
Decompensated chronic liver disease Definition of decompensated chronic liver disease Patients with chronic liver disease can present with acute decompensation due to various causes. The decompensation
More informationAlcoholic liver disease
Phil Jackson MBChB UKDICM FRCA Dermot Gleeson MD BSc FRCP Matrix reference 3D03 Key points Alcoholic liver disease is increasing in incidence and may have a variety of manifestations. Good general supportive
More informationKing s College Hospital NHS Foundation Trust. Acute on Chronic Liver Failure: Practical management outside the tertiary centre.
King s College Hospital NHS Foundation Trust NHS Acute on Chronic Liver Failure: Practical management outside the tertiary centre. William Bernal Professor of Liver Critical Care Liver Intensive Therapy
More informationA RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS
A RARE CASE OF SEPTIC SHOCK SECONDARY TO PRIMARY STERNOCLAVICULAR JOINT SEPTIC ARTHRITIS Dr Ehab F. Girgis & Dr Daniel S.Z.M. Boctor National Health Service, UK TAKE HOME MESSAGES 1. SCJ Septic Arthritis
More informationHepatitis C Virus (HCV)
Clinical Practice Guidelines Hepatitis C Virus (HCV) OBJECTIVE The purpose is to guide the appropriate diagnosis and management of Hepatitis C Virus (HCV). GUIDELINE These are only guidelines, and are
More informationEnd-Stage Liver Disease (ESLD): A Guide for HIV Physicians
Slide 1 of 32 End-Stage Liver Disease (ESLD): A Guide for HIV Physicians Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California
More informationWhat s new in Hepatology AASLD 2016
What s new in Hepatology AASLD 2016 CWN Spearman C Kassianides What s new in Hepatology? AASLD 2016 CWN SPEARMAN Hepatitis C Alcoholic liver disease Cholestatic Liver Disease Primary biliary Cholangitis
More informationInvestigating and Referring Incidental Findings of Abnormal Liver Tests
Investigating and Referring Incidental Findings of Abnormal Liver Tests Note on Referral Guidelines: these revised guidelines are presented as a tool to aid appropriate referral and management of common
More informationApproach to the Patient with Liver Disease
Approach to the Patient with Liver Disease Diagnosis of liver disease Careful history taking Physical examination Laboratory tests Radiologic examination and imaging studies Liver biopsy Liver diseases
More informationManagement of Chronic Liver Failure/Cirrhosis Complications in Hospitals. By: Dr. Kevin Dolehide
Management of Chronic Liver Failure/Cirrhosis Complications in Hospitals By: Dr. Kevin Dolehide Overview DX Cirrhosis and Prognosis Compensated Decompensated Complications Of Cirrhosis Management Of Complications
More informationInvestigations before OLT, Immunosuppression and rejection, Follow up after OLT.
Investigations before OLT, Immunosuppression and rejection, Follow up after OLT andrea.degottardi@insel.ch When is liver transplantation indicated? When is liver transplantation indicated? Frequent: CIRRHOSIS
More informationJaundice. Agnieszka Dobrowolska- Zachwieja, MD, PhD
Jaundice Agnieszka Dobrowolska- Zachwieja, MD, PhD Jaundice definition Jaundice, as in the French jaune, refers to the yellow discoloration of the skin. It arises from the abnormal accumulation of bilirubin
More informationHepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors
Hepatitis C: Management of Previous Non-responders with First Line Protease Inhibitors Fred Poordad, MD The Texas Liver Institute Clinical Professor of Medicine University of Texas Health Science Center
More informationDeveloped for Scotland by the National Plasma Product Expert Advisory Group. Clinical Guidelines for Human Albumin Use
Approved by NPPEAG 28 May 2018 Reviewed 1 June 2018 To be reviewed 1 June 2020 Developed for Scotland by the National Plasma Product Expert Advisory Group Clinical Guidelines for Human Albumin Use 1 National
More informationKing Abdul-Aziz University Hospital (KAUH) is a tertiary
Modelling Factors Causing Mortality in Oesophageal Varices Patients in King Abdul Aziz University Hospital Sami Bahlas Abstract Objectives: The objective of this study is to reach a model defining factors
More informationOptimal management of auto-immune
collaborations des équipes impliquées dans l' explorati en charge des ef ets indésirables des immunothérapies INSCRIPTIONS BLIC : cialistes d organe, Chercheur s, ovigilants ns l es toxicités es anti-cancéreuses.
More informationInterpreting Your Tests
Interpreting Your Tests Lisa M. Forman, MD, MSCE Associate Professor of Medicine Section Hepatology and Liver Transplantation University of Colorado Denver Outline Bile Duct Anatomy Lab Tests LFTs Tumor
More informationCauses of Liver Disease in US
Learning Objectives Updates in Outpatient Cirrhosis Management Jennifer Guy, MD MAS Director, Liver Cancer Program California Pacific Medical Center guyj@sutterhealth.org Review cirrhosis epidemiology,
More informationManagement of alcoholic hepatitis: Implications for options beyond the STOPAH study
Management of alcoholic hepatitis: Implications for options beyond the STOPAH study Gyongyi Szabo, MD, PhD Professor University of Massachusetts Medical School Worcester, MA Cape Town, South Africa 2015
More informationManagement of Alcohol Dependence
STANDARD TREATMENT GUIDELINES Management of Alcohol Dependence Quick Reference Guide February 2016 Ministry of Health & Family Welfare Government of India 1 Table of Contents Objectives-... 3 Diagnosis...
More informationDRAFT FOR CONSULTATION
In patients with acute alcoholic hepatitis, what is the safety and efficacy of corticosteroids v placebo? Reference Carithers RL, Jr., Herlong HF, Diehl AM et al. Methylprednisolone therapy in patients
More informationESLD a Guide for HIV Physicians. Marion Peters University of California San Francisco June 2015
ESLD a Guide for HIV Physicians Marion Peters University of California San Francisco June 2015 Disclosures Honararia from Johnson and Johnson Roche Merck Gilead Spouse employee of Hoffman La Roche Natural
More informationEvaluating HIV Patient for Liver Transplantation. Marion G. Peters, MD Professor of Medicine University of California San Francisco USA
Evaluating HIV Patient for Liver Transplantation Marion G. Peters, MD Professor of Medicine University of California San Francisco USA Slide 2 ESLD and HIV Liver disease has become a major cause of death
More information